Bacteria in your mouth might reveal how depressed you are, scientists say
Depression could be linked to a lack of diversity in the bacteria in your mouth, according to new research.
As you read this, your mouth contains between 500 billion and 1 trillion bacteria. After the gut microbiome, the orifice is the second-largest community of microorganisms in human bodies.
Now, researchers at New York University say the makeup of those microbes could be used to help diagnose and treat depression. In a new study, they found that less diversity of microbes in the mouth is associated with the mental health condition.
'It's possible that the oral microbiome influences depressive symptoms through inflammation or changes to the immune system. Conversely, depression can drive changes including dietary intake, poor oral hygiene, increased smoking and drinking, or the use of medications—all of which have the potential to alter the oral microbiome,' Dr. Bei Wu, vice dean for research at NYU Rory Meyers College of Nursing, said in a statement. 'We need more research to understand the direction and underlying pathways of this relationship.'
Wu is the senior author of the study, which was published this week in the journal BMC Oral Health.
To reach these conclusions, the authors examined data from the Centers for Disease Control and Prevention's National Health and Nutrition Examination Survey. They used questionnaire data from more than 15,000 adults collected between 2009 and 2012 to compare symptoms of depression with saliva samples.
They also used gene sequencing to identify the microbes in the saliva and measure the diversity of the oral microbiome. That's how they found that people with less microbial diversity were more likely to have symptoms of depression.
Additional analysis revealed that practices including smoking, drinking, and dental care influenced the relationship between the oral microbiome and depression. They can all change the makeup of bacteria in the mouth.
They noted that antidepressants and other psychotropic medications have side effects that can lead to reduced saliva and alter the oral microenvironment.
'Thus, medications not only alleviate depressive symptoms but also have a regulatory effect on oral health,' they said.
Still, it remains unclear whether the diversity of microbes in the mouth influences depression, if depression leads to changes in the oral microbiome, or if there's a symbiotic relationship.
They noted that a recent study found a potential link between depression and the diversity of bacteria in the gut, and that a growing body of research points to a connection between the oral microbiome and overall health. That's thought to be driven by inflammation and disruptions to the immune system.
They hope these findings will support a greater understanding of the issue. In 2021, an estimated 21 million adults had at least one major depressive episode in the past year.
'Having a better understanding of the relationship between the oral microbiome and depression could not only help us learn about the mechanisms underlying depression, but could contribute to the development of new biomarkers or treatments for mood disorders,' said Wu.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
34 minutes ago
- Daily Mail
I still breastfeed my three-year-old daughter - people say it's disturbing but it has saved her from stunted growth
A mother-of-two who breastfed her daughter up until she was three years old has hit back at criticism from trolls as she claims her decision has helped her child's development. Madison Simpson, who has documented her breastfeeding journey on TikTok, where she has more than 28,000 followers, has been told her approach is 'disturbing' and criticised for 'confusing' her daughter, Amaya. Known online as 'The Breastfeeding Momma', the 22-year-old, who appears to hail from the American South, advocates for 'extended breastfeeding'. Content creator Madison, who is from the US, posted a video of her blissfully breastfeeding her little girl earlier this year - when her daughter was approaching three - but it received a very negative reaction. One person commented: 'It's time to STOP! This is disturbing seeing how that child is bigger than you.' In the 30-second clip captioned 'Comfort nursing and bonding after the journey is over is okay too', Madison is holding Amaya in her arms and swaying to music as her daughter suckles on her breast. Amaya, who was born with Intrauterine Growth Restriction (IGR) weighed just over four pounds at birth and was expected to develop into a tiny child. Although Madison struggled to breastfeed her first child, son Amirion, she didn't have any issues with her daughter. And, at one month old, Amaya was already exceeding the growth expectations of her medical team, with Madison attributing her daughter's quick and impressive progress to breastfeeding. Madison, who is herself very petite, decided to continue in the same vein, nursing Amaya well beyond her second birthday - always breastfeeding and never giving her a bottle. The mother has also acknowledged that breastfeeding soothes her daughter, telling People that she puts Amaya 'on the boob and [lets] it be like a human pacifier.' TikTokers were largely unimpressed with Madison's video, with some vehemently opposed to her 'extended breastfeeding' approach. One person commented: 'It's time to STOP! This is disturbing seeing how that child is bigger than you.' Reacting to Amaya's height, which appears to be above average for a toddler, Another added: 'At that point you're nursing a whole child'. A third was especially judgmental, writing: 'Insecurity if a kid that age still needs a boobie for comfort. Clearly she has already developed food issues.' Referring to Amaya, a fourth said: 'Very confusing for her'. While a fifth person commented: 'She's a big girl. Does she eat solids or strictly breast milk?' One person, however, leapt to Madison's defence, adding: 'I am so sorry you are receiving such hateful comments. What a blessing it is to have given your baby three years'. Yet, unperturbed by all the negativity, Madison hit back at her detractors in a subsequent video posted on TikTok five days ago. She responded directly to US comedian and actor Brandon Trusso, who publicly mocked the young mother when he said: 'That is not a child. 'It has a 401 (k) plan and a reverse mortgage.' A 401 (k) plan is a type of retirement plan offered by US employers to their employees to help them save for when they've left the workforce. Madison strongly defended her choice when she said: '[Amaya] is three years old. 'I quit breastfeeding around four or five months ago and she is no longer breastfed. 'It doesn't look normal to you because I am literally the size of a 12-year-old. I am 4 feet 11 [and] 90 pounds soaking wet.' She went on to criticise Brandon for 'trying to down a mother for breastfeeding and giving away her body to a child.' Madison said: 'Do you know how many years of hard work and dedication that it took to breastfeed her?' The mother also noted in the video that it's normal in some countries to breastfeed up until seven. She ended the clip by pointing out that she helps 'a lot of moms' with her page - and that Brandon was also putting them down for breastfeeding their children. Madison then showed a picture of her daughter and said: 'Now does she look like she's off to college with a 401 (k) plan? She's three.'
Daily Mail
an hour ago
- Daily Mail
Fewer wrinkles in one WEEK: The potent serum that works 11 times faster than standard retinol (and it's gentle, too)
You're constantly fine-tuning your beauty routine. If one of your primary goals is to reduce visible lines and wrinkles, you may have your work cut out for you. But if you're tired of that song and dance, it's time to turn your attention to Medik8. The brand's Crystal Retinal Age Defying Night Serum could well be considered the end-all, be-all of anti-aging treatments — because it's available in multiple progressive strengths to help your skin become more tolerant over time. Medik8 Crystal Retinal Age Defying Night Serum Take control of aging skin once and for all with the serum clinically proven to reveal skin that both looks and feels younger in just a week. It's available in six progressive strengths, making it easy for anyone — even those with sensitive skin — to take advantage of retinal's efficacy. Used regularly, it virtually erases fine lines, wrinkles, and age spots while firming skin and leaving your complexion firm and glowing. $85 Shop Its key ingredient is retinal, a derivative of vitamin A that works 11 times faster than standard retinol to visibly reduce those signs of aging you've tried so desperately to erase. Fine lines? Deep-set creases? They're no match for this system. It's really quite genius. Medik8 offers six different Crystal Retinal formulas. The first in the range is specifically designed to meet the needs of sensitive skin, which means even those who've never been able to use standard retinol can finally reap the rewards and see results — without the risk of those unwelcome side effects. As your skin grows accustomed to the treatment, you can ladder up to beginner level 3 before advancing to levels 6, 10, and 20. The final formula in the range, 24, is for experts whose skin can tolerate the higher concentration. The results are truly astonishing at every level. A whopping 100 percent of people felt the serum was 'gentle,' while 97 percent noted their skin looked more youthful. Impressively, in a clinical trial participants experienced a 20 percent reduction in both wrinkles and dark spots, along with an 11 percent improvement in firmness. Those are exactly the kinds of results you expert of an anti-aging product — but very few deliver the way that Medik8's game-changing solution does. In fact, it's clinically proven to smooth away wrinkles in just one week, with improved elasticity in four. The benefits are the same no matter which formula you choose: a smoother, more radiant, more refined complexion that is free of stubborn wrinkles, dark spots, and congestion. Medik8 stabilizes its formulas to ensure that they remain potent to the very end of the tube, so you never have to worry about them losing their efficacy. In other words, you truly get your money's worth — making this advanced skin care worth every penny. Thousands of reviewers agree that it's made all the difference. 'Beautiful results with no side effects,' praised one shopper. 'My skin has never looked better, it's smooth and clear and starting to feel much firmer.' 'Really see a different in fine lines and skin texture using this! The texture is beautiful, a lovely silky formula that absorbs well and doesn't feel like it just sits on the skin,' raved another customer. What more could you ask for than an anti-aging treatment that is both gentle and widely regarded for delivering visible results? Pick up the Medik8 Crystal Retinal Age Defying Night Serum and get set for a more youthful complexion!
The Independent
an hour ago
- The Independent
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs
Americans would likely pay more for necessary everyday prescription drugs, such as insulin, painkillers, chemotherapy, or antibiotics, if President Donald Trump were to enact tariffs on pharmaceuticals, experts warn. In an effort to incentivize drug manufacturers to bring production back to the United States, Trump has proposed tariffing pharmaceuticals made overseas – which account for an overwhelming majority of everyday medicine used in the U.S. 'We're going to be doing that,' Trump said of pharmaceutical tariffs in April. 'That's going to be like we have on cars. You know we have a 25 percent tariff on cars, we have a 25 percent tariff on steel and aluminum, and that's what the [pharmaceutical] category fits right now.' 'The higher the tariff, the faster they come,' Trump said. But experts say that's not necessarily true and there would be tangible consequences to such action, from higher brand-name drug prices to generic drug shortages. 'If tariffs were applied to prescription drugs, one of the most immediate consequences could be price increases — on prices that we already pay way in excess of other countries,' Dr. Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, said. The U.S. imports a majority of its branded prescription drugs – or medications that are patented with a brand name such as Viagra, Wegovy, or Zoloft – from high-income countries. Dr. Jeromie Ballreich, an associated research professor at Johns Hopkins Bloomberg School of Public Health, said much of the manufacturing comes from Ireland, Germany, and Switzerland because they have favorable tax policies for companies. As a result, adding a tariff would only make it more expensive for pharmacies and insurance companies to keep them in supply. 'We would expect pharma to pass the costs onto the insurers and we would expect insurers to pass the cost onto the individual patients,' Ballreich said. 'So, if there is a 50 percent tariff on your insulin product because it's coming from Ireland, patients in Mississippi who get insulin – they will either be faced with a higher cost when they go up to the pharmacy to fill their insulin or they're going to face a higher indirect cost because the premiums of the insurance plan are going to go up,' he said. Ballreich said a tariff on countries that produce high quantities of branded drugs would put 'pressure' on public insurers like Medicare or Medicaid and private insurers. However, branded drugs only account for roughly 10 to 15 percent of prescriptions. A majority of Americans, up to 90 percent, use generic drugs, often manufactured in India and China, because they're cheaper. Making branded drugs less accessible through tariffs would only increase reliance on generic drugs, which could exacerbate shortages that already impact millions of Americans. Generic drugs would become less available '[Shortages] can have very significant implications in day-to-day clinical practice,' Socal said. 'For example, if you are administering chemotherapy for an oncology patient, that may have significant consequences even for the prognosis of that case moving forward.' In 2024, the U.S. experienced a shortage of more than 300 drugs – 70 percent of which were generic prescriptions. Socal said that when patients are not able to access a more affordable version of their prescription, it means they may put their health at risk by skipping a dosage, taking a lower dosage, or not filling their prescription at all. Otherwise, they're forced to turn to the more expensive branded version. 'Those more expensive drugs are not always the best,' Socal said. 'Very frequently, and we saw this with chemotherapy shortages, the available drugs are second-line drugs.' Tariffs won't necessarily increase domestic manufacturing The president has indicated that any negative impact from tariffs may be temporary and worth it to bring manufacturing and jobs back. 'We're doing it because we want to make our own drugs,' Trump said. But Ballreich and Socal are more skeptical. 'Tariffs are a very blunt instrument to incentivize domestic U.S. manufacturing of the branded drugs we use,' Ballreich said. Given pharmaceutical companies have moved outside of the U.S. for tax purposes, Ballreich says tax policy may be a better way to incentivize them, especially since many of those drugs are more difficult to manufacture. 'It's not just a very simple chemical plant; these tend to be very complex,' he said. Socal suggested a better strategy would be to understand where drugs are being manufactured and which ones would make more sense to bring to the U.S. — since even those manufactured locally often rely on certain imported ingredients and materials. 'Having tariffs on pharmaceutical products coming from abroad can actually also hurt our domestic manufacturers,' he says. While the president has not officially implemented any tariff policy on pharmaceuticals yet, he said, in April, that the plan would take effect in the 'not too distant future.'
